Iveric Bio receives new therapy designation for avacincaptad pegol
FDA grants status following primary endpoint data from pivotal trials treating geographic atrophy
Read More
Tag: avacincaptad
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
- Fabentech secures French approval for Ricimed antidote
- Oxford Drug Design reports major in vivo milestone for novel cancer therapy
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
